Canada has suspended the Oxford / Astrageneca coronavirus vaccine for minors as a “precautionary measure” due to concerns in Europe that the shot may be associated with rare blood clots.
National Advisory Committee on Immunization a Statement On Monday it recommended that the AstraZeneca vaccine “should not be used at this time in people under the age of 55” and that the role of the shot in potential cases of “rare cases of severe blood clotting” be further investigated.
Examples of these blood clots in people who recently shot AstraZeneca in Europe are “primarily” in women under the age of 55, although some cases have occurred in men, Nassi said in his statement. “The rate of this adverse event is still uncertain,” it said.
Supriya Sharma, chief medical adviser to Health Canada, told a news conference on Monday that the authorities still have “insufficient information” on whether the risk is greater than the benefit to younger people, but added that in the case of people 60 or older, ” Working “”
The Canadian provinces, including Manitoba and Prince Edward Island, have said they will immediately stop using the AstraZeneca vaccine on adults.
Earlier this month, more than a dozen European countries reported a low platelet count and bleeding in a limited number of patients, for a break or limited use of the AstraZeneca shot after a rare and fatal combination of blood clots in the brain. Some patients died. The United Kingdom has registered a number of cases but has not stopped or restricted the use of the shot.
The European Medicines Agency examined whether there was a link between shots and the overall risk of blood clots, but determined that there was none. Nevertheless, regulators have left the door open there for a possible link between side effects and a rare combination of vaccines. Surveillance continues, but most countries have resumed operating the JAB.
The break is a major blow to Europe’s sick vaccination campaign, which lags behind the United States and the United Kingdom. Throughout the crisis, both the EMA and the World Health Organization recovered that the benefits of the shot outweighed its potential risks – even if rare and severe blood clots and a link between the shots appeared.
AstraZeneca stressed that its vaccine is safe and has been given to millions of people around the world, with both real-world and clinical evidence showing it is safe and effective.